Company / Current Liabilities
Boston Scientific Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$5.4B
FY2025
5-year range
$3.8B / $6.4B
FY2021-FY2025
Trend
-15.0%
vs FY2024
Sector context
#19 of 160
Health Care
What the data says
Boston Scientific's current liabilities of $5.4B is higher than 88% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 10 years, ranging from $3.6B in FY2016 to $6.4B in FY2024.
Based on SEC 10-K filings.
$5.4B in FY2025 with a 5-year CAGR of +8.1%. Top quartile in the Health Care sector.
Increased from $4.9B to $5.4B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +12.7%
- 5-Year CAGR
- +8.1%
- 10-Year CAGR
- -
Sector benchmark
+21.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +8.1%, indicating consistent growth.
- In FY2025, current liabilities decreased 15.0% year-over-year.
- Ranks #19 out of 160 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.4B | -15.0% |
| FY2024 | $6.4B | +29.7% |
| FY2023 | $4.9B | +29.7% |
| FY2022 | $3.8B | -11.0% |
| FY2021 | $4.3B | +16.1% |
| FY2020 | $3.7B | -24.4% |
| FY2019 | $4.9B | -7.5% |
| FY2018 | $5.3B | -7.0% |
| FY2017 | $5.7B | +57.6% |
| FY2016 | $3.6B | +47.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026